BioSpace News Archive

Business

Polyganics Builds New Facility to Continue Growth, Supported by RIG Subsidy of €3.8 Million

Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, is expanding its capacity with a new facility at the Zernike Campus, Groningen, to enter a new phase of commercial and R&D growth.

April 10, 2019
·
4 min read
Drug Development

Alligator Bioscience to Present New Preclinical Data on ATOR-1015 at PEGS Boston

Tumor-localizing properties of bispecific antibody demonstrated by live imaging

April 10, 2019
·
3 min read
Deals

Notice of Annual General Meeting of Medivir AB (publ)

The shareholders of Medivir AB are hereby summoned to the annual general meeting on Thursday 9 May 2019 at 2 p.m. at the IVA’s conference center, Grev Turegatan 16, Stockholm.

April 10, 2019
·
9 min read
BioForest

Principal Gift From United Arab Emirates To Support Development Of Children’s National Research & Innovation Campus

Builds on longstanding partnership to advance global pediatric health

April 10, 2019
·
4 min read
Drug Development

Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia

Concert Pharmaceuticals, Inc. announced that it has initiated an additional trial in the Phase 1 program evaluating CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive treatment for schizophrenia.

April 10, 2019
·
7 min read
Deals

Realm Therapeutics Announces 2018 Annual Report Available and Form 20-F Filing

Realm Therapeutics plc announces that its 2018 Annual Report is now available on the Company’s website, www.realmtx.com, and will be posted to those shareholders who have not elected to receive the document electronically.

April 10, 2019
·
1 min read
Business

Aurora Cannabis Provides Construction Update on Aurora Sun

Facility Footprint Increased to 1.6 Million Square Feet, Target Capacity 230,000+ kg per Annum

April 10, 2019
·
8 min read
Pharm Country

Evogen Awarded National Institutes of Health SBIR Grant to Advance Its Novel Biomarker-Based Epilepsy Diagnostic

Collaboration with Human Epilepsy Project will Enhance Evogen’s Blood-Based Biomarker Test with the Potential to Transform Epilepsy Diagnosis

April 10, 2019
·
4 min read
CannTrust Launches Three New Medical Cannabis Product Formulations

Highest Dose CBD Capsule on the Canadian Market Fills Unmet Need

April 10, 2019
·
6 min read
Drug Development

Can-Fite Announces Late-Breaking Abstract Presentation on Namodenoson™ Phase II Results at the American Association of Clinical Oncology (ASCO) Annual Meeting

Acceptance for late breaking oral presentation underscores the oncology community’s interest in Namodenoson as a potential treatment for liver cancer

April 10, 2019
·
6 min read